ARCHIVES

Chabner Criticizes FDA Crackdown On Off-Label Info

This article is from The Cancer Letter archive.

Vol. 17 No. 26 | June 28, 1991

Download PDF Visit The Full Archive

Related Articles

Freireich’s Seven Laws To Protect Against Obstacles To Clinical Research

May 14, 1976

NCI Advisory Group, Other Cancer Meetings

February 28, 1986

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

NCI Proposed 1980 Budget Increases R01 Grants By $50 Million Over ’79; Total – $1.055 Billion

June 9, 1978

In Brief: Search Narrows ACS Head; Selections For Breast Cancer Commission Still At HHS

March 27, 1992